Positron CorpOTC Pink - Current Information:POSC
- LAST PRICE1.0000
- TODAY'S CHANGE (%)-0.0900 (-8.2569%)
- Bid / Lots0.9180/ 10
- Ask / Lots1.1000/ 2
- Open / Previous Close1.0800 / 1.0900
- Day Range
- 52 Week Range
- Volume3,950
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | POSC |
|---|---|---|
| 11:39 ET | 600 | 1.08 |
| 11:43 ET | 100 | 1.0825 |
| 11:45 ET | 400 | 1.08 |
| 12:51 ET | 1500 | 1.08 |
| 01:54 ET | 200 | 1.08 |
| 02:41 ET | 1000 | 1.09 |
| 03:44 ET | 100 | 1 |
Yesterday
Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings, from 9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
9:30AM ET on Thursday Nov 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Positron Corp | 28.3M | -11.1x | --- |
Renalytix PLC | 32.5M | -0.2x | --- |
Adagio Medical Holdings Inc | 30.5M | -13.3x | --- |
Know Labs Inc | 25.9M | -1.2x | --- |
Icecure Medical Ltd | 29.6M | -2.4x | --- |
Inspira Technologies Oxy BHN Ltd | 24.9M | -1.4x | --- |
Company Information
Positron Corporation is a molecular imaging device company, which offers a positron emission tomography (PET) imaging system and clinical services to nuclear medicine healthcare providers throughout North America. The Company is specialized in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. Its PET technology, clinical services and imaging practice solutions enables healthcare providers to diagnose coronary artery disease and improve patient outcomes through providing medicine. It offers nuclear cardiologists its Attrius PET nuclear imaging device, technical and clinical services, and can provide financing solutions to meet the needs of hospitals and medical imaging practices. Its products and services enables healthcare providers to diagnose CAD and improve patient outcomes.
Contact Information
- Headquarters
- 1777 Maryland AveNIAGARA FALLS, NY, United States 14305
- Phone
- 317-813-0673
- Fax
- 845-818-3588
Executives
- Director
- Adel Abdullah
- Vice President
- Aaron Hargrave
- Independent Director
- Anthony Nicholls
- Independent Director
- Sachio Okamura
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $28.3M |
|---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 25.9M |
Positron Corp does not pay a dividend. | |
Beta | 0.56 |
EPS | $-0.09 |
Book Value | $-0.06 |
P/E Ratio | -11.1x |
Price/Sales (TTM) | 22.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -126.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
